No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
HALO Halozyme Therapeutics
- 46.960
- -0.360-0.76%
Close Dec 20 16:00 ET
- 46.960
- 0.0000.00%
Post 20:01 ET
5.97BMarket Cap15.55P/E (TTM)
48.205High46.880Low4.79MVolume47.030Open47.320Pre Close226.09MTurnover3.81%Turnover Ratio22.36P/E (Static)127.23MShares65.53352wk High13.20P/B5.91BFloat Cap33.15052wk Low--Dividend TTM125.91MShs Float65.533Historical High--Div YieldTTM2.80%Amplitude1.410Historical Low47.152Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Those Who Invested in Halozyme Therapeutics (NASDAQ:HALO) Five Years Ago Are up 159%
HC Wainwright & Co. Reiterates Buy on Halozyme Therapeutics, Maintains $68 Price Target
Johnson & Johnson Says Injectable Rybrevant Rejected by FDA
How Much Upside Is Left in Halozyme Therapeutics (HALO)? Wall Street Analysts Think 27.08%
If You Invested $1000 in Halozyme Therapeutics a Decade Ago, This Is How Much It'd Be Worth Now
(HALO) - Analyzing Halozyme Therapeutics's Short Interest
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock the Full List